We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Director dealings: Victoria non-exec invests, Faron Pharma CFO sells entire holding

Tue 13 January 2026 13:03 | A A A

No recommendation

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

(Sharecast News) - Shares in Victoria saw director support on Tuesday, after the group disclosed that non-executive director Steve Callaghan purchased 260,000 ordinary shares at 37.93p each on 9 January.

The transaction, carried out on the London Stock Exchange, gave Callaghan a holding of 260,000 shares, representing around 0.23% of the company's issued share capital, according to the regulatory filing.

Separately, Faron Pharmaceuticals reported that its chief financial officer, Jurriaan Dekkers, sold his entire holding of 4,000 ordinary shares at 182.2p per share on 12 January.

Following the sale, which was executed on AIM, Dekkers no longer holds any shares or voting rights in the clinical-stage immunotherapy company.

Reporting by Josh White for Sharecast.com.

Top Director Buys

Victoria (VCP)

Director name: Callaghan,Stephen James

Amount purchased: 260,000 @ 37.93p

Value: 98,618.00

Guardian Metal Resources (GMET)

Director name: Starzecki ,J.T

Amount purchased: 37,250 @ 149.00p

Value: 55,502.50

Lindsell Train Investment Trust (LTI)

Director name: Lindsell,Michael

Amount purchased: 5,000 @ 648.92p

Value: 32,446.13

Guardian Metal Resources (GMET)

Director name: Friesen,Oliver

Amount purchased: 20,100 @ 148.00p

Value: 29,748.00

Bp (BP.)

Director name: Howle,Carol

Amount purchased: 73 @ 425.60p

Value: 310.69

Centrica (CNA)

Director name: O'Shea,Chris

Amount purchased: 83 @ 180.84p

Value: 150.10

Centrica (CNA)

Director name: O'Brien,Russell

Amount purchased: 83 @ 180.84p

Value: 150.10

Sabre Insurance Group (SBRE)

Director name: Carter,Geoffrey Richard

Amount purchased: 112 @ 133.62p

Value: 149.65

Sthree (STEM)

Director name: Beach,Andrew

Amount purchased: 82 @ 181.81p

Value: 149.08

Croda International (CRDA)

Director name: Foots,Steve

Amount purchased: 5 @ 2,714.00p

Value: 135.70

Bp (BP.)

Director name: Thomson ,Kate

Amount purchased: 5 @ 425.60p

Value: 21.28

Top Director Sells

Faron Pharmaceuticals Oy (di) (FARN)

Director name: Dekkers,Jurriaan

Amount sold: 4,000 @ 182.20p

Value: 7,288.00

    The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.